SHORT-TERM OUTCOMES OF SURGICAL TREATMENT OF PANCREATIC NEUROENDOCRINE TUMORS ASSOCIATED WITH THE SYNDROME OF MULTIPLEENDOCRINE NEOPLASIA TYPE 1-Reference-Cited by-同舟云学术

SHORT-TERM OUTCOMES OF SURGICAL TREATMENT OF PANCREATIC NEUROENDOCRINE TUMORS ASSOCIATED WITH THE SYNDROME OF MULTIPLEENDOCRINE NEOPLASIA TYPE 1

Published:2019-12-15 Issue:1 Volume:21 Page:72-75
ISSN:2687-1424
Container-title:Bulletin of the Russian Military Medical Academy
language:
Short-container-title:Bulletin of the Russian Military Medical Academy

Author:

Egorov A V,Vasilyev I A,Ivashov I V,Thakur A S

Abstract

Background: pancreaticneuroendocrine tumors occur in almost all patients with multiple endocrine neoplasia type 1 (MEN1) and are a major cause of death. Surgical resection is the only potentially curative therapy for pNETs, otherwise various endocrine syndromesdevelop threatening the patient's life. Aim: to evaluate the short-term results of surgical management of patients with pancreatic neuroendocrine tumors with MEN1. Materials and methods: by last 20 years, 40 patients with pancreatic neuroendocrine tumors within MEN1 were operated. Results: in the early postoperative period,according to the classification of Clavien-Dindo, complications occurred in 12 (26%) patients. The following types of complications were diagnosed: IIIa in 6 patients; IIIb - in 2; type V in 4 patients. Complications of types I, II and IV were not identified. Conclusion: less percentage of postoperative complications is achieved by performing organ-preserving operations, after precise imaging diagnose, due to minimal intraoperative pancreatic injury.

Publisher

ECO-Vector LLC

Reference7 articles.

1. Crippa S., Zerbi A., Boninsegna L. et al. Surgical Management of Insulinomas: Short- and Long-term Outcomes After Enucleations and Pancreatic Resections. //Arch. Surg. - 2012. - Vol.147, №3. -P. 261-266.

2. Calender, A.; Cadiot, G.; Mignon M. Multiple endocrine neoplasia type 1: Genetic and clinical aspects. Gastroenterol. Clin. Biol. 2001, 25, 38-48.

3. Chanson, P.; Cadiot, G.; Murat, A. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Grouped’Etude des NéoplasiesEndocriniennes Multiples de type 1. Horm. Res. 1997, 47, 211-220.

4. Franko J, Feng W, Yip L, Genovese E and Moser AJ: Non-functional neuroendocrine carcinoma of the pancreas: Incidence, tumor biology, and outcomes in 2,158 patients. J GastrointestSurg 14: 541-548, 2010.

5. Niina Y, Fujimori N, Nakamura T, et al. The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1. Gut Liver 2012;6:287-94.